Angiotensin-receptor blockers: Benefits beyond lowering blood pressure
Russell L. Silverstein, MD
Senior Physician and Vice President, Dallas Nephrology Associates, Dallas, TX
C. Venkata S. Ram, MD
Director, Texas Blood Pressure Institute, Dallas Nephrology Associates; University of Texas Southwestern Medical School, Dallas, TX
Address: C. Venkata S. Ram, MD, Director, Texas Blood Pressure Institute, 1420 Viceroy Drive, Dallas, TX 75235; e-mail firstname.lastname@example.org
ABSTRACTA number of controlled clinical trials provide evidence that angiotensin-receptor blockers improve the prognosis in a variety of conditions that place patients at high cardiovascular risk. The effect is more than one would expect from the effect of these agents on blood pressure alone. The results of some of these trials have expanded the indications for these drugs.